Deoxythymidine kinase in the staging of prostatic adenocarcinoma

Prostate

Volumn 29, Issue 1, 1996, Pages 15-19

  Letocha, Henry ^a   Eklöv, Solveig ^a   Gronowitz, Simon ^a   Norlén, Bo Johan ^a   Nilsson, Sten ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

deoxythymidine kinase (dTK); localized disease; metastatic disease; prognostic value; prostate specific antigen (PSA); prostatic adenocarcinoma; staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; THYMIDINE KINASE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; THYMIDINE KINASE;

EID: 0029975618     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199607)29:1<15::AID-PROS2>3.0.CO;2-H     Document Type: Article

References (19)

1. The Cancer Registry. Cancer incidence in Sweden 1989. Stockholm: Centre for Epidemiology, National Board of Health and Welfare, 1992.
2. Boring CC, Squires TS, Tong T. Cancer Statistics 1992. Cancer 42:19-38, 1992.
3. Schmidt JD, Mettlin CJ, Natarjan N, Peace BB, Beart RW, Winchester DP, Murphy GD. Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol 139:416-421, 1986.
4. Häggman M. Localized prostatic cancer: a study of diagnosis, staging and prognostic factors. Comprehensive summaries of Uppsala dissertations from the Faculty of Medicine 427. Uppsala: Acta Universitatis Upsaliensis, 1993.
5. Stamey TA. Cancer of the prostate. Monogr Urol 3:67-94, 1982.
6. Norberg M, Häggman M, Andersson T, Busch C, Magnusson A. Evaluation of localized prostatic cancer. A comparative study of transrectal ultrasonography versus histopathology. Eur Radiol 3:166-173, 1993.
7. Varenhorst E, Berglund K, Löfman O, Pedersen K. Inter-observer variability in the assessment of the prostate by digital rectal examination. Br J Urol 72:173-176, 1993.
8. Pedersen KV, Herder A. Radical retropubic prostatectomy for localised prostatic carcinoma: a clinical and pathological study of 201 cases. Scand J Urol Nephrol 27:219-224, 1993.
9. Mukamel E, Hannah J, Barbaric Z, deKernion JB. The value of computerized tomography and magnetic resonance imaging in the staging of prostatic carcinoma: comparison with clinical and histopathological staging. J Urol 136:1231-1233, 1986.
10. Magnusson A, Fritjofsson Å, Norlén BJ, Wicklund H. The value of computed tomography and ultrasound assessment of pelvic node metastases in patients with clinically locally confined carcinoma of the prostate. Scand J Urol Nephrol 22:7-10, 1988.
11. Saitoh H, Yoshida KI, Ushijima Y, Kobayashi N, Suwata J, Kamata S. Two different lymph node metastatic patterns of a prostatic cancer. Cancer 65:1843-1846, 1990.
12. Oesterling JE. Prostate-specific antigen: a critical assessment of the most useful tumour markers for adenocarcinoma of the prostate. J Urol 145:907-923, 1991.
13. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Prostate-specific antigen in the staging of localized prostate cancer: influence of tumour differentiation, tumour volume and benign hyperplasia. J Urol 143:747-752, 1990.
14. Bresnick E, Mainigi K, Mayfield E, Morris E. Activity of enzymes of purimidine nucleotide synthesis in slowly growing kidney tumours. Cancer Res 29:1932-1936, 1969.
15. Gordon H, Bardos T, Chmielewicz Z, Ambrus J. Comparative study of thymidine kinase and thymidilate kinase activities and of feedback inhibition of thymidine kinase in normal and neoplastic human tissue. Cancer Res 28:2068-2077, 1968.
16. Gronowitz S, Källander C, Hagberg H, Diderholm H, Pettersson U. Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int J Cancer 33:5-12, 1984.
17. Gronowitz S, Hagberg H, Källander C, Simonsson B. The use of serum deoxythymidine kinase as a prognostic marker and in the monitoring of patients with non-Hodgkin lymphoma. Br J Cancer 47:487-495, 1983.
18. Gronowitz S, Steinholz L, Källander C, Hagberg H, Bergh J. Serum thymidine kinase in small cell lung cancer: relation to clinical features, prognosis and other biochemical markers. Cancer 58:111-118, 1986.
19. Lewenhaupt A, Ekman P, Eneroth P, Nilsson B. Tumour markers as prognostic aids in prostatic carcinoma. Br J Urol 66:182-187, 1990.